LYRINEL

This brand name is authorized in Ireland, United Kingdom, South Africa

Active ingredients

The drug LYRINEL contains one active pharmaceutical ingredient (API):

1 Oxybutynin hydrochloride UNII L9F3D9RENQ - OXYBUTYNIN CHLORIDE

Oxybutynin acts as a competitive antagonist of acetylcholine at post-ganglionic muscarinic receptors, resulting in relaxation of bladder smooth muscle. Read about Oxybutinin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LYRINEL XL Prolonged release tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BD04	Oxybutynin	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 381479, 45292, 45295
Country: IE	Health Products Regulatory Authority	Identifier(s): 32300, 32309, 32329, 32383
Country: ZA	Health Products Regulatory Authority	Identifier(s): A39/5.4/0212, A39/5.4/0224